Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis

BACKGROUND: Honokiol has been reported to possess anti-inflammatory and neuroprotective activities. However, the poor aqueous solubility of honokiol limits its clinical application for systemic administration. PURPOSE: This study aims to develop a novel formulation of nanosome-encapsulated honokiol...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Yai-Ping, Chen, Hui-Ting, Liang, Yu-Chih, Wang, Tse-En, Huang, Kai-Hung, Hsu, Cheng-Chih, Liang, Hong-Jen, Huang, Chung-Hsiung, Jan, Tong-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954093/
https://www.ncbi.nlm.nih.gov/pubmed/32021162
http://dx.doi.org/10.2147/IJN.S214349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954093/
https://www.ncbi.nlm.nih.gov/pubmed/32021162
http://dx.doi.org/10.2147/IJN.S214349

Ejemplares similares